J. Goldman & Co LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$10,143,000
+142.4%
95,451
+36.2%
0.43%
+96.4%
Q4 2017$4,184,000
-58.8%
70,062
-83.4%
0.22%
-57.0%
Q3 2017$10,154,000
+25.2%
423,100
+2.0%
0.51%
+16.6%
Q2 2017$8,109,000
+200.0%
414,800
+260.2%
0.44%
+227.6%
Q1 2017$2,703,000
+6.6%
115,150
-44.3%
0.13%
-20.2%
Q4 2016$2,535,000
+28.0%
206,600
+14.3%
0.17%
-1.2%
Q3 2015$1,981,000
+18.3%
180,716
+24.6%
0.17%
-0.6%
Q2 2013$1,675,000145,0000.17%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders